Skip to content

Monash expert: NASA discovers ‘Super-Earth’ 137 light-years away

Monash University 2 mins read

A Monash University expert is available to comment on a new 'super-Earth' which NASA has discovered that orbits in a habitable zone and is 137 light-years away.

Associate Professor Michael Brown, School of Physics and Astronomy, Faculty of Science, Monash University
Contact:  +61 3 9903 4840 or
Read more of Associate Professor Brown’s commentary at Monash Lens

The following can be attributed to Associate Professor Brown:

“With improvements in telescopes and methods, more planets beyond our Solar System are being discovered, with over 5,000 now known. Some planets are even big enough that amateur astronomers and students can detect their presence around nearby stars.

“Very large gas giant planets that orbit close to their stars are relatively easy to discover. However, these ‘hot Jupiters’ are probably not suitable habitats for life. 

“There’s been great interest in finding smaller planets that are similar to the Earth in size and mass, that would have surface temperatures suitable for rivers and oceans, and thus potentially life. 

“TOI-715 b may be such a planet. It’s three times the mass of the Earth and the right distance from its star to potentially have liquid water. 

“This is exciting but there’s good reasons for caution. We know very little about the atmosphere and surface of this planet. TOI-715 b also orbits close to a cool M-type star, whereas the Earth orbits further away from a hotter G-type star - and perhaps being this close to an M-type star could complicate the development of life. 

“More planets with sizes and masses comparable to Earth will be found in the habitable zones of stars, and in the coming years and decades they will be the prime targets for searches for life beyond the Earth.”

For any other topics on which you may be seeking expert comment, please contact the Monash University Media team on +61 3 9903 4840 or

More from this category

  • Science
  • 18/06/2024
  • 22:08
Takeda Pharmaceutical Company Limited

Takeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA® in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting

Favorable Findings fromthe Longest Public Clinical Study in CIDP Support HYQVIA as an Effective Long-Term Treatment Option for Maintaining Stable Disease Course in CIDP…

  • Contains:
  • Medical Health Aged Care, Science
  • 18/06/2024
  • 12:30

WEHI spinout company set to revolutionise homegrown cancer treatments

Australia has cemented its role in becoming a major player in the next-generation of medicines with the launch of Ternarx – a globally competitive biotechnology company dedicated to finding new treatments for hard to treat cancers. The WEHI spinout is the first of its kind in Australia dedicated to developing targeted protein degrader medicines and technology, a powerful new tool for destroying disease-causing proteins that cannot be targeted by conventional drugs. Ternarx, which is backed by $15 million in funding from the Medical Research Future Fund’s (MRFF) Frontier Health and Medical Research initiative and by support from WEHI, has been…

  • Contains:
  • Science
  • 18/06/2024
  • 02:37
Nexeo Plastics

GPD Companies, Inc. Names Kurt Schuering as President and Chief Executive Officer

Paul Tayler to Retire and Remain on Board of DirectorsTHE WOODLANDS, TX / ACCESSWIRE / June 17, 2024 / GPD Companies, Inc. ("GPD"), an affiliate of One Rock Capital Partners, LLC ("One Rock"), today announced the appointment of Kurt Schuering as President and CEO, effective June 24, 2024. Paul Tayler will retire from his role as President and CEO and remain on GPD's Board of Directors. Schuering brings nearly 30 years of experience in the plastics industry and a proven track record of success, making him the ideal candidate to lead GPD into its next phase of growth and innovation.…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.